Page results
-
This information explains what alpha thalassaemia is, and provides information about the different types of alpha thalassaemia.
-
This information page aims to answer some of the questions you may have about receiving chimeric antigen receptor (CAR) T-cell therapy at University College London Hospitals NHS Foundation Trust (UCLH).
-
Information about community sickle cell and thalassaemia services provided via UCLH.
-
Over half a million non-sterile blue gloves have been saved from landfill since we launched our Gloves Off initiative in May last year.
-
This information is about penile cancer multidisciplinary team (MDT), the a team of professionals who will be caring for you at University College Hospital (UCLH).
-
Professor David Choi is a consultant neurosurgeon. He sees patients with common conditions such as back and neck pain, disc problems, nerve root impingement, through to complex problems of spine and skull base tumours, endoscopic and craniocervical junction surgery.
-
This patient information will describe what having a transverse vaginal septum means, how it can affect you, and what are the treatment options.
-
This patient information will describe what having a transverse vaginal septum means, how it can affect you, and what are the treatment options.
-
Information about sickle cell disorder in adulthood for UCLH patients.
-
This patient information is about obstructed hemi-vaginas.
File results
-
FOI/2022/0194 - Drug treatment for lung cancer
-
FOI/2022/0199 - Trust postal service and patient communication
-
FOI/2022/0200 - IT budget/ chatbots
-
FOI/2022/0205 - Spending on communication activities
-
FOI/2022/206 - Rates for Bonham Carter House 52-54 Gower Street
-
FOI/2022/0207 - Patient treatment with Nivolumab
-
FOI/2022/0209 - Patient tracking list or waiting lists
-
FOI/2022/0211 - Enteral feeding machine mechanical insufflator
-
FOI/2022/0212 - Clotting disorders medication
-
FOI/2022/0214 - Prostate Cancer (Summary Funding and costs of Xtandi (Enzalutamide) trial: NCT00974311) Xtandi (Enzalutamide) trial, NCT00974311